Prevalence, predictors and evolution of echocardiographically defined cardiac abnormalities in adults with type 1 diabetes: An observational cohort study

Journal of Diabetes and its Complications

Volumn 28, Issue 1, 2014, Pages 22-28

  Wai, Bryan ^a,b   Patel, Sheila K ^a   Ord, Michelle ^b   Macisaac, Richard J ^c   Jerums, George ^a,b   Srivastava, Piyush M ^a,b   Burrell, Louise M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Cardiac disease; Diastolic dysfunction; Echocardiography; Left ventricular hypertrophy; Type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ALBUMINURIA; AMBULATORY CARE; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CARDIOMETABOLIC RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DISEASE DURATION; DISEASE SURVEILLANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; OBSERVATIONAL STUDY; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART DISEASES; HEART LEFT VENTRICLE FUNCTION; HYPERTROPHY, LEFT VENTRICULAR; PROGNOSIS; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC CARDIOMYOPATHIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84891835163     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.09.013     Document Type: Article

References (29)

1. E. Adal, G. Koyuncu, A. Aydin, A. Celebi, G. Kavunoglu, and H. Cam Asymptomatic cardiomyopathy in children and adolescents with type 1 diabetes mellitus: Association of echocardiographic indicators with duration of diabetes mellitus and metabolic parameters Journal of Pediatric Endocrinology & Metabolism 19 2006 713 726
2. American Diabetes Association (2013). Standards of medical care in diabetes - 2013. Diabetes Care 36 (supplement 1), S11-S66.
3. R. Candido, J.M. Forbes, M.C. Thomas, V. Thallas, R.G. Dean, and W.C. Burns et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes Circulation Research 92 2003 785 792
4. A.M. From, C.G. Scott, and H.H. Chen The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study Journal of the American College of Cardiology 55 2010 300 305
5. S. Genuth, J.Y. Backlund, M. Bayless, D.A. Bluemke, P.A. Cleary, and J. Crandall et al. Effects of prior Intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC Diabetes 62 2013 3561 3569
6. K. Gul, A.S. Celebi, F. Kacmaz, O.C. Ozcan, I. Ustun, and D. Berker et al. Tissue Doppler imaging must be performed to detect early left ventricular dysfunction in patients with type 1 diabetes mellitus European Journal of Echocardiography 10 2009 841 846
7. G.C. Kane, B.L. Karon, D.W. Mahoney, M.M. Redfield, V.L. Roger, and J.C. Burnett Jr. et al. Progression of left ventricular diastolic dysfunction and risk of heart failure JAMA 306 2011 856 863
8. T.D. Karamitsos, H.I. Karvounis, E.G. Dalamanga, C.E. Papadopoulos, T.P. Didangellos, and D.T. Karamitsos et al. Early diastolic impairment of diabetic heart: The significance of right ventricle International Journal of Cardiology 114 2007 218 223
9. E.H. Kim, and Y.H. Kim Left ventricular function in children and adolescents with type 1 diabetes mellitus Korean Circulation Journal 40 2010 125 130
10. E. Konduracka, A. Gackowski, P. Rostoff, D. Galicka-Latala, W. Frasik, and W. Piwowarska Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: No evidence for its occurrence in the era of intensive insulin therapy European Heart Journal 28 2007 2465 2471
11. S.P. Laing, A.J. Swerdlow, S.D. Slater, A.C. Burden, A. Morris, and N.R. Waugh et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes Diabetologia 46 2003 760 765
12. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology Journal of the American Society of Echocardiography 18 2005 1440 1463
13. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group Annals of Internal Medicine 130 1999 461 470
14. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study New England Journal of Medicine 322 1990 1561 1566
15. M. Lind, I. Bounias, M. Olsson, S. Gudbjornsdottir, A.M. Svensson, and A. Rosengren Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: An observational study Lancet 378 2011 140 146
16. W.C. Little, M.R. Zile, D.W. Kitzman, W.G. Hundley, T.X. O'Brien, and R.C. Degroof The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure Journal of Cardiac Failure 11 2005 191 195
17. J. Mathew, P. Sleight, E. Lonn, D. Johnstone, J. Pogue, and Q. Yi et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril Circulation 104 2001 1615 1621
18. P.M. Okin, R.B. Devereux, E. Gerdts, S.M. Snapinn, K.E. Harris, and S. Jern et al. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study Circulation 113 2006 1588 1596
19. Y.S. Park, J.H. Park, K.T. Ahn, W.I. Jang, H.S. Park, and J.H. Kim et al. Usefulness of mitral annular systolic velocity in the detection of left ventricular systolic dysfunction: Comparison with three dimensional echocardiographic data Journal of Cardiovascular Ultrasound 18 2010 1 5
20. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr., D.W. Mahoney, K.R. Bailey, and R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
21. M. Salem, S. El Behery, A. Adly, D. Khalil, and E. El Hadidi Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus Pediatric Diabetes 10 2009 513 521
22. C.M. Schannwell, M. Schneppenheim, S. Perings, G. Plehn, and B.E. Strauer Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy Cardiology 98 2002 33 39
23. N.B. Schiller Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography Circulation 84 1991 I280 I287
24. B. Shivalkar, D. Dhondt, I. Goovaerts, L. Van Gaal, J. Bartunek, and P. Van Crombrugge et al. Flow mediated dilatation and cardiac function in type 1 diabetes mellitus American Journal of Cardiology 97 2006 77 82
25. S.S. Soedamah-Muthu, J.H. Fuller, H.E. Mulnier, V.S. Raleigh, R.A. Lawrenson, and H.M. Colhoun High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: A cohort study using the general practice research database Diabetes Care 29 2006 798 804
26. S.D. Solomon, R. Janardhanan, A. Verma, M. Bourgoun, W.L. Daley, and D. Purkayastha et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: A randomised trial Lancet 369 2007 2079 2087
27. P.M. Srivastava, P. Calafiore, R.J. Macisaac, S.K. Patel, M.C. Thomas, and G. Jerums et al. Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with type 2 diabetes Clinical Science (London, England) 114 2008 313 320
28. P.M. Srivastava, M.C. Thomas, P. Calafiore, R.J. Macisaac, G. Jerums, and L.M. Burrell Diastolic dysfunction is associated with anaemia in patients with type II diabetes Clinical Science (London, England) 110 2006 109 116
29. A. Vazeou, A. Papadopoulou, M. Miha, A. Drakatos, and D. Georgacopoulos Cardiovascular impairment in children, adolescents, and young adults with type 1 diabetes mellitus (T1DM) European Journal of Pediatrics 167 2008 877 884